C.H. Robinson Worldwide is one of the largest third-party logistics (3PL) providers globally, specializing in non-asset-based freight brokerage, transportation management, and supply chain solutions. The company connects approximately 75,000 customers with a network of roughly 450,000 contract carriers, managing 37 million shipments and $23 billion in freight annually. Its core North American Surface Transportation (NAST) segment accounts for roughly three-quarters of revenue, complemented by a growing Global Forwarding division covering air and ocean freight. The company's Lean AI strategy has driven significant productivity gains, automating shipment pricing, carrier matching, and cargo monitoring. Investors track CHRW closely as a bellwether for freight demand, industrial activity, and broader macroeconomic health.
Over the last 30 days, CHRW shares plunged from $193.50 on July 10 to $149.35 as of the August 7 close — a decline of approximately 22.8%. The selloff was concentrated in two waves: an initial 9.3% drop on July 24 following news of the Texas nuclear verdict, and a massive 15.4% single-day collapse on July 30 after the Q2 earnings report and conference call. The quarterly trend tells a similarly turbulent story. From mid-May levels around $170, the stock rallied to an all-time 52-week high of $210.33 before the dual shocks of legal liability and cautious guidance erased those gains and pushed shares well below their starting point for the quarter.
The single largest catalyst was the July 23 jury verdict in Lipe v. Lupus Superior, which handed down approximately $604 million in damages against C.H. Robinson and co-defendants. As the first major trial outcome since the U.S. Supreme Court's Montgomery v. Caribe Transport II ruling in May 2026 — which stripped away federal preemption protections for freight brokers — the decision sent shockwaves through the 3PL industry. The jury found C.H. Robinson 23% responsible and controversially determined the carrier's driver was effectively a "borrowed employee" of the broker. The verdict triggered an immediate selloff not only in CHRW but also in peers like RXO and LSTR.
Days later, the Q2 2026 earnings report on July 29 deepened the rout. While adjusted EPS of $1.61 beat consensus estimates of $1.53 and revenue surged 19.3% to $4.93 billion, management warned of decelerating industry volume growth — revising its outlook to a range of -3% to +1% from a prior flat-to-5% growth expectation. This effectively signaled that full-year adjusted EPS could land around $6.00, below the $6.20 consensus. Compounding concerns, operating cash flow collapsed to $35.9 million from $227.1 million a year earlier, driven by a $227.3 million adverse swing in net working capital tied to higher freight rates. Citigroup had already downgraded the stock to Neutral on June 15, flagging valuation risk when shares traded near $199.
The broader quarterly narrative is one of a sharp boom-to-bust cycle. CHRW rallied strongly through late spring and early summer, driven by tightening truckload capacity, firmer spot rates, enthusiasm around AI-driven margin expansion, and multiple analyst price target increases. Stifel raised its target to $215, Wells Fargo to $215, and Baird set a $230 target. The stock hit $210.33 on July 21 — a 52-week high and a gain of roughly 24% from mid-May lows. However, the rally was built on a stretched valuation exceeding 42 times forward earnings, leaving no cushion when negative catalysts emerged. The Montgomery ruling in May had already planted seeds of legal risk, and the Texas verdict crystallized those fears. By the time Q2 results landed, the combination of legal overhang, cautious guidance, and deteriorating cash generation was too much for the elevated multiple to sustain, reversing nearly all the quarter's gains in a matter of days.
In periods of heightened volatility, traders and investors increasingly turn to automated strategies to help navigate rapidly shifting market conditions. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong recent performance across thousands of stocks. These bots employ diverse strategies — ranging from swing trading to longer-term trend following — and vary by timeframe, asset class, and risk profile. Only top-performing and most relevant bots appear in this curated section, offering users a streamlined way to explore algorithmic trading approaches tailored to current market dynamics. Browsing the Trending AI Robots page can provide traders with actionable insight into how data-driven strategies are positioning in real time.
The most critical factor for CHRW going forward is the trajectory of the Lipe v. Lupus Superior appeal. CEO Dave Bozeman has expressed confidence that the verdict will be overturned or significantly reduced on appeal, but the process could take years, leaving lingering uncertainty around potential financial exposure, insurance coverage, and broader industry precedent. Investors should also monitor any regulatory or legislative responses — particularly whether the FMCSA or Congress moves to establish clearer carrier selection standards for brokers. On the operational side, freight demand trends, spot rate movements, and the company's ability to sustain its mid-cycle margin targets through Lean AI productivity gains will be closely watched. The next earnings report, expected in early November, will be pivotal in assessing whether the volume deceleration warning was conservative or the start of a deeper freight slowdown. Additionally, the Deutsche Bank Industrials Summit appearance on August 11 may provide incremental clarity on management's strategic outlook.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The 10-day moving average for CHRW crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHRW as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CHRW turned negative on July 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
CHRW moved below its 50-day moving average on July 27, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CHRW's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRW advanced for three days, in of 349 cases, the price rose further within the following month. The odds of a continued upward trend are .
CHRW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 246 cases where CHRW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CHRW's P/B Ratio (10.537) is very high in comparison to the industry average of (3.175). P/E Ratio (28.000) is within average values for comparable stocks, (200.624). Projected Growth (PEG Ratio) (2.012) is also within normal values, averaging (1.971). Dividend Yield (0.017) settles around the average of (0.019) among similar stocks. P/S Ratio (1.044) is also within normal values, averaging (2.272).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CHRW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of multimodal transportation services and logistics solutions
Industry OtherTransportation